МИКОПЛАЗМА-ИММУН®

General characteristics. Structure:

Active ingredients - specific antibodies to  Mycoplasma hominis.

excipients: glycine (glycine, the aminoacetic acid), sodium chloride.

Main properties: transparent or with insignificant opalescence, colourless or yellowish liquid. At storage emergence of the insignificant deposit disappearing when stirring is allowed. Drug contains immunological the active protein fraction allocated from serum or the blood plasma of the person checked for lack of antibodies to VICh-1, VICh-2, to a virus of hepatitis C and a surface antigen of a virus of hepatitis B, cleared and concentrated by a fractionation method the spirtovodny besieging solutions to the virus inactivation which passed a stage solvent-detergentnym with method. Protein content in 1.0 ml of drug from 0:09 g to 0:11 g. The antiserum capacity to Mycoplasma hominis has to make not less than 1:80. Drug does not contain preservative and antibiotics.

Pharmacological properties:

The operating basis of drug is the immunoglobulin G specific to  Mycoplasma hominis. Activity of drug is caused by action of antibodies. Immunoglobulin G, influencing different links of immune system of the person, causes also immunomodulatory effect, and increases nonspecific resistance of an organism.

Indications to use:

Drug is used for treatment of mycoplasmosis.

Route of administration and doses:

Drug is used intramusculary. Enter 3 ml once in three days. The course of treatment makes up to 7 injections.

Features of use:

It is forbidden to administer the drug intravenously! After the termination of a period of validity use of drug is inadmissible. Drug is not subject to requality control and extension of a period of validity after its termination.

Side effects:

Side effects, as a rule, are absent. In rare instances local reactions in the form of a hyperemia, and also temperature increase to ^{37.5 0C} within the first days can develop. Some persons with the changed reactivity can have allergic reactions of different type, and in exclusively exceptional cases - an acute anaphylaxis. In this regard the patients who received drug have to be under medical observation within 30 minutes.

Interaction with other medicines:

At treatment of patients with urogenital pathology  it is necessary to appoint immunoglobulin against Mycoplasma hominis along with antibiotics from group of macroleads (сумамед or doxycycline). It is most effective during pregnancy a combination therapy (immunoglobulin against  Mycoplasma hominis and Rovamycinum).

Contraindications:

Administration of drug is contraindicated to the persons having heavy allergic reactions to introduction of proteinaceous blood preparations of the person in the anamnesis. The patient having allergic diseases, or having a serious allergic illness in the anamnesis in day of administration of drug and in the next 3 days recommends antihistaminic drugs. To the persons suffering from immune general diseases (diseases of blood, connecting fabric, nephrite, etc.), it is necessary to administer the drug against the background of the corresponding therapy.

Overdose:

It was not studied.

Storage conditions:

In the dry, protected from light place at a temperature from 2 °C to 8 °C.

Issue conditions:

According to the recipe

Packaging:

On 1.5 ml (1 dose) of drug in an ampoule. On 3, 5 or 10 ampoules in a pack.